Journal: Amino Acids
Article Title: Evaluation of the clinical characteristics and potentially prognostic factors in HER2-positive breast cancer
doi: 10.1007/s00726-025-03494-x
Figure Lengend Snippet: Representative IHC images of CD38, Cyclin D1, EGFR, ESR1 and TDO2 of breast cancer tissues according to molecular subtypes of HR+ /HER2+ and HR–/HER2+. The expression of CD38, Cyclin D1, EGFR, ESR1 and TDO2 were positively related to the status of HR in HER2+ breast cancer tissues. The immunohistochemistry analysis in breast cancer tissue were at 10 × and 40 × magnification. The locations of CD38, Cyclin D1, EGFR, ESR1 and TDO2 were all mainly expressed in nucleus
Article Snippet: The antibody of CD38 (Proteintech, USA, 25284-1-AP), Cyclin D1 (Proteintech, USA, 26939-1-AP), EGFR (Proteintech, USA, 18986-1-AP), ESR1 (Affinity Biosciences, USA, AF6058) and TDO2 (Proteintech, USA, 15880-1-AP) were used in the process of IHC staining.
Techniques: Expressing, Immunohistochemistry